KEAP1 and non-small cell lung carcinoma: In the current study, we investigated whether tumour-intrinsic KEAP1/NRF2 mutations could be non-invasively imaged by [18F]FSPG PET imaging and whether aberrant system xc− expression could be exploited for treatment of refractive NSCLC tumours.